677 related articles for article (PubMed ID: 16473279)
1. X chromosomal abnormalities in basal-like human breast cancer.
Richardson AL; Wang ZC; De Nicolo A; Lu X; Brown M; Miron A; Liao X; Iglehart JD; Livingston DM; Ganesan S
Cancer Cell; 2006 Feb; 9(2):121-32. PubMed ID: 16473279
[TBL] [Abstract][Full Text] [Related]
2. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
Vincent-Salomon A; Ganem-Elbaz C; Manié E; Raynal V; Sastre-Garau X; Stoppa-Lyonnet D; Stern MH; Heard E
Cancer Res; 2007 Jun; 67(11):5134-40. PubMed ID: 17545591
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.
Ganesan S; Richardson AL; Wang ZC; Iglehart JD; Miron A; Feunteun J; Silver D; Livingston DM
Cold Spring Harb Symp Quant Biol; 2005; 70():93-7. PubMed ID: 16869742
[TBL] [Abstract][Full Text] [Related]
4. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.
Sirchia SM; Ramoscelli L; Grati FR; Barbera F; Coradini D; Rossella F; Porta G; Lesma E; Ruggeri A; Radice P; Simoni G; Miozzo M
Cancer Res; 2005 Mar; 65(6):2139-46. PubMed ID: 15781624
[TBL] [Abstract][Full Text] [Related]
5. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
Pageau GJ; Hall LL; Lawrence JB
J Cell Biochem; 2007 Mar; 100(4):835-50. PubMed ID: 17146760
[TBL] [Abstract][Full Text] [Related]
7. Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.
Focken T; Steinemann D; Skawran B; Hofmann W; Ahrens P; Arnold N; Kroll P; Kreipe H; Schlegelberger B; Gadzicki D
Cytogenet Genome Res; 2011; 135(2):84-92. PubMed ID: 22024613
[TBL] [Abstract][Full Text] [Related]
8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
9. Gene body-specific methylation on the active X chromosome.
Hellman A; Chess A
Science; 2007 Feb; 315(5815):1141-3. PubMed ID: 17322062
[TBL] [Abstract][Full Text] [Related]
10. Association of BRCA1 with the inactive X chromosome and XIST RNA.
Ganesan S; Silver DP; Drapkin R; Greenberg R; Feunteun J; Livingston DM
Philos Trans R Soc Lond B Biol Sci; 2004 Jan; 359(1441):123-8. PubMed ID: 15065664
[TBL] [Abstract][Full Text] [Related]
11. BCoR-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract][Full Text] [Related]
12. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
13. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
14. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells.
Kawakami T; Zhang C; Taniguchi T; Kim CJ; Okada Y; Sugihara H; Hattori T; Reeve AE; Ogawa O; Okamoto K
Oncogene; 2004 Aug; 23(36):6163-9. PubMed ID: 15195139
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for BRCA1 communication with the inactive X chromosome.
Silver DP; Dimitrov SD; Feunteun J; Gelman R; Drapkin R; Lu SD; Shestakova E; Velmurugan S; Denunzio N; Dragomir S; Mar J; Liu X; Rottenberg S; Jonkers J; Ganesan S; Livingston DM
Cell; 2007 Mar; 128(5):991-1002. PubMed ID: 17350581
[TBL] [Abstract][Full Text] [Related]
16. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
Vincent-Salomon A; Gruel N; Lucchesi C; MacGrogan G; Dendale R; Sigal-Zafrani B; Longy M; Raynal V; Pierron G; de Mascarel I; Taris C; Stoppa-Lyonnet D; Pierga JY; Salmon R; Sastre-Garau X; Fourquet A; Delattre O; de Cremoux P; Aurias A
Breast Cancer Res; 2007; 9(2):R24. PubMed ID: 17417968
[TBL] [Abstract][Full Text] [Related]
17. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
19. The molecular pathology of hereditary breast cancer.
Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]